Feed BDSX
BD

Biodesix, Inc.

BDSX · NASDAQ

$26.97 +3.24% (+$0.85)
1M +12.37%
Market Cap $212.0M
P/E Ratio -
Div. Yield -
ROE 788.19%

Bulios Fair Price

$29.32

8.7% upside

Trenutna cena

$26.97

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica BDSX trenutno podcenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Moderate
4/9
Valuation
37 /100
Fair
P/S 2.06x
P/B 23.18x
P/E N/A
Growth
100 /100
Growing
Rev. growth 32.31%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak
Gross margin 82.50%
Net margin 26.97%
Op. margin 20.01%
Quality
14 /100
Poor
ROIC 25.22%
ROE 788.19%
ROA 29.12%
Debt
23 /100
High
Debt/Equity 7.85x
Current ratio 2.85x
Int. coverage -2.45x
Stability
82 /100
Stable
Beta 0.59x
Rev. volatility 11.20%
EPS volatility 14.96%

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o BDSX
Online

O podjetju

Biodesix, Inc. is a biopharmaceutical company focused on the development and commercialization of diagnostic tests for the detection and monitoring of various diseases, particularly cancer and lung diseases. The company specializes in utilizing advanced technologies such as proteomics and genetics to identify biomarkers and develop diagnostic tests that help physicians better understand the patient's condition and choose more effective treatment strategies. Biodesix is known for its innovative approaches to diagnostics and its efforts to provide personalized medicine through precise diagnostic tests. Biodesix, Inc. could be suitable for investors seeking opportunities in the biotechnology sector with an emphasis on diagnostics and personalized medicine.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Scott Hutton

Employees

334

Headquarters

Louisville

Prihajajoči dogodki

02 NOV.

Earnings

Upcoming earnings report

50d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.